Top PCR Molecular Diagnostics Companies

The global PCR molecular diagnostics market features a competitive landscape with several key players striving to gain a significant market share. These companies invest in research and development activities to develop innovative PCR-based diagnostic tests and technologies. They also focus on strategic collaborations, mergers and acquisitions, and partnerships to expand their product portfolio and geographical presence. The competitive landscape is dynamic, with ongoing advancements and product launches by key players. For example, companies such as bioMérieux SA, Meridian Bioscience, Inc., and Luminex Corporation have introduced new PCR-based diagnostic assays targeting specific infectious diseases and genetic disorders. This continuous innovation and product development contribute to the growth and competitiveness of the market.

Top Player’s Company Profiles

• F. Hoffmann-La Roche Ltd (Switzerland)

• Thermo Fisher Scientific Inc. (US)

• Abbott Laboratories (US)

• Qiagen N.V. (Netherlands)

• Bio-Rad Laboratories, Inc. (US)

• Agilent Technologies, Inc. (US)

• Danaher Corporation (US)

• Hologic, Inc. (US)

• Siemens Healthineers AG (Germany)

• PerkinElmer, Inc. (US)

• Becton, Dickinson and Company (US)

• bioMérieux SA (France)

• Meridian Bioscience, Inc. (US)

• GenMark Diagnostics, Inc. (US)

• QIAGEN Manchester Ltd (UK)

• Luminex Corporation (US)

• Grifols, S.A. (Spain)

• Gen-Probe Incorporated (US)

• ELITech Group (France)

• Merck KGaA (Germany)